# Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer

> **NCT00861094** · PHASE2,PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 266 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** 5-FU
- **DRUG:** oxaliplatin
- **RADIATION:** radiation therapy
- **DRUG:** Folinic Acid

## Key facts

- **NCT ID:** NCT00861094
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2011-09
- **Final completion:** 2012-12
- **Target enrollment:** 266 (ACTUAL)
- **Last updated:** 2015-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861094, "Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00861094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*